Differential profiling of patients with different meningioma grades and recurrences revealed that mRNA levels of immunoglobulin superfamily containing leucine-rich repeat 2 (ISLR2), anti-mullerian hormone (AMH), and lncRNA-GOLGA6A-1 exhibited the highest prognostic power to predict meningioma recurrence (Table 1) [72]. This evidence concerns the gene GOLGA6A and meningioma.